{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:24Z","timestamp":1761100524689,"version":"3.30.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,6,1]]},"DOI":"10.1038\/sj.bmt.1702432","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:36:48Z","timestamp":1031153808000},"page":"1219-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation"],"prefix":"10.1038","volume":"25","author":[{"given":"EA","family":"Copelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SL","family":"Penza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PJ","family":"Elder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SA","family":"Ezzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MD","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TP","family":"Bechtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PS","family":"Belt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BR","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,6,19]]},"reference":[{"key":"BF1702432_CR1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.7326\/0003-4819-112-12-932","volume":"112","author":"BD Cheson","year":"1990","unstructured":"Cheson BD . The myelodysplastic syndromes: current approaches to therapy Ann Intern Med 1990 112: 932\u2013941","journal-title":"Ann Intern Med"},{"key":"BF1702432_CR2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V82.2.677.677","volume":"82","author":"JE Anderson","year":"1993","unstructured":"Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome Blood 1993 82: 677\u2013681","journal-title":"Blood"},{"key":"BF1702432_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/10428199509051708","volume":"17","author":"JE Anderson","year":"1995","unstructured":"Anderson JE, Appelbaum FR, Storb R . An update on allogeneic marrow transplantation for myelodysplastic syndrome Leuk Lymphoma 1995 17: 95\u201399","journal-title":"Leuk Lymphoma"},{"key":"BF1702432_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V87.1.51.51","volume":"87","author":"JE Anderson","year":"1996","unstructured":"Anderson JE, Appelbaum FR, Schoch G et al. Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors Blood 1996 87: 51\u201358","journal-title":"Blood"},{"key":"BF1702432_CR5","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1182\/blood.V81.8.2194.2194","volume":"81","author":"V Ratanatharathorn","year":"1993","unstructured":"Ratanatharathorn V, Karanes C, Uberti J et al. Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes Blood 1993 81: 2194\u20132199","journal-title":"Blood"},{"key":"BF1702432_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1200\/JCO.1996.14.1.220","volume":"14","author":"JE Anderson","year":"1996","unstructured":"Anderson JE, Appelbaum FR, Schoch G et al. Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors J Clin Oncol 1996 14: 220\u2013226","journal-title":"J Clin Oncol"},{"key":"BF1702432_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1200\/JCO.1997.15.2.566","volume":"15","author":"F Locatelli","year":"1997","unstructured":"Locatelli F, Niemeyer C, Angelucci E et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on myelodysplastic syndrome in childhood J Clin Oncol 1997 15: 566\u2013573","journal-title":"J Clin Oncol"},{"key":"BF1702432_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Gluckberg","year":"1974","unstructured":"Gluckberg H, Storb R, Fefer A et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295\u2013304","journal-title":"Transplantation"},{"key":"BF1702432_CR9","first-page":"545","volume":"19","author":"HM Shulman","year":"1978","unstructured":"Shulman HM, Sale GE, Lerner KG et al. Chronic cutaneous graft-versus-host disease in man Am J Pathol 1978 19: 545\u2013570","journal-title":"Am J Pathol"},{"key":"BF1702432_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"11","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 11: 255\u2013267","journal-title":"Ann Intern Med"},{"key":"BF1702432_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.7326\/0003-4819-111-5-368","volume":"111","author":"JG Clark","year":"1989","unstructured":"Clark JG, Crawford SW, Madtes DK, Sullivan KM . Obstructive lung disease after allogeneic marrow transplantation Ann Intern Med 1989 111: 368\u2013376","journal-title":"Ann Intern Med"},{"key":"BF1702432_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF1702432_CR13","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 1966 50: 163\u2013170","journal-title":"Cancer Chemother Rep"},{"key":"BF1702432_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life tables J Roy Stat Soc 1972 34: 187\u2013220","journal-title":"J Roy Stat Soc"},{"key":"BF1702432_CR15","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","volume":"70","author":"PJ Tutschka","year":"1987","unstructured":"Tutschka PJ, Copelan EA, Klein JP . Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen Blood 1987 70: 1382\u20131388","journal-title":"Blood"},{"key":"BF1702432_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"313","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-vs-host disease after marrow transplantation for leukemia New Engl J Med 1986 313: 729\u2013735","journal-title":"New Engl J Med"},{"key":"BF1702432_CR17","first-page":"445","volume":"10","author":"TJ Nevill","year":"1992","unstructured":"Nevill TJ, Shepherd JD, Reece DE et al. Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT Bone Marrow Transplant 1992 10: 445\u2013450","journal-title":"Bone Marrow Transplant"},{"key":"BF1702432_CR18","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1200\/JCO.1995.13.12.2973","volume":"13","author":"MR O'Donnell","year":"1995","unstructured":"O'Donnell MR, Long GD, Parker PM et al. Busulfan\/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia J Clin Oncol 1995 13: 2973\u20132979","journal-title":"J Clin Oncol"},{"key":"BF1702432_CR19","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","volume":"84","author":"RA Clift","year":"1994","unstructured":"Clift RA, Buckner CD, Thomas ED et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide Blood 1994 84: 2036\u20132043","journal-title":"Blood"},{"key":"BF1702432_CR20","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V80.7.1648.1648","volume":"80","author":"E Copelan","year":"1992","unstructured":"Copelan E, Deeg J . Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation Blood 1992 80: 1648\u20131658","journal-title":"Blood"},{"key":"BF1702432_CR21","first-page":"171","volume":"18","author":"MJ Styler","year":"1999","unstructured":"Styler MJ, Crilley P, Biggs J et al. Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective multi-center analysis Bone Marrow Transplant 1999 18: 171\u2013176","journal-title":"Bone Marrow Transplant"},{"key":"BF1702432_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00007890-198907000-00015","volume":"48","author":"EA Copelan","year":"1989","unstructured":"Copelan EA, Kapoor N, Berliner M, Tutschka PJ . Bone marrow transplantation without total body irradiation in patients 40 and older Transplantation 1989 48: 65\u201368","journal-title":"Transplantation"},{"key":"BF1702432_CR23","first-page":"285a","volume":"92","author":"E Copelan","year":"1998","unstructured":"Copelan E, Penza S, Theil K et al. Allogeneic marrow transplantation with BuCy2 in patients with chronic myelogenous leukemia Blood 1998 92: 285a","journal-title":"Blood"},{"key":"BF1702432_CR24","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V79.10.2578.bloodjournal79102578","volume":"79","author":"D Blaise","year":"1992","unstructured":"Blaise D, Maraninchi D, Archimbaud E et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Groupe d'Etudes de la Greffe de Moelle Osseuse Blood 1992 79: 2578\u20132582","journal-title":"Blood"},{"key":"BF1702432_CR25","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","volume":"83","author":"O Ringden","year":"1994","unstructured":"Ringden O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplant Group Blood 1994 83: 2723\u20132730","journal-title":"Blood"},{"key":"BF1702432_CR26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood.V78.3.838.838","volume":"78","author":"EA Copelan","year":"1991","unstructured":"Copelan EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2 Blood 1991 78: 838\u2013843","journal-title":"Blood"},{"key":"BF1702432_CR27","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T et al. for the Nordic Bone Marrow Transplantation Group Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia Blood 1999 93: 2196\u20132201","journal-title":"Blood"},{"key":"BF1702432_CR28","doi-asserted-by":"publisher","first-page":"pp53","DOI":"10.1007\/978-1-59259-657-7_4","volume-title":"Current Controversies in Bone Marrow Transplantation","author":"EA Copelan","year":"2000","unstructured":"Copelan EA . Are busulfan-based preparative regimens equivalent, worse, or better than total body irradiation regimens? In: Bolwell BJ (ed) Current Controversies in Bone Marrow Transplantation Humana Press: Clifton, NJ 2000 pp53\u201367"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702432","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T11:07:50Z","timestamp":1733569670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6,1]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,6,1]]}},"alternative-id":["BF1702432"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702432","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2000,6,1]]},"assertion":[{"value":"15 September 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}